|
1
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
2
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jones PA and Laird PW: Cancer epigenetics
comes of age. Nat Genet. 21:163–167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis: epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Derks S, Postma C, Moerkerk PT, et al:
Promoter methylation precedes chromosomal alterations in colorectal
cancer development. Cell Oncol. 28:247–257. 2006.PubMed/NCBI
|
|
7
|
Esteller M: Epigenetic lesions causing
genetic lesions in human cancer: promoter hypermethylation of DNA
repair genes. Eur J Cancer. 36:2294–2300. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Frigola J, Solé X, Paz MF, et al:
Differential DNA hypermethylation and hypomethylation signatures in
colorectal cancer. Hum Mol Genet. 14:319–326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esteller M and Herman JG: Generating
mutations but providing chemosensitivity: the role of
O6-methylguanine DNA methyltransferase in human cancer. Oncogene.
23:1–8. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pegg AE: Mammalian O6-alkylguanine-DNA
alkyltransferase: regulation and importance in response to
alkylating carcinogenic and therapeutic agents. Cancer Res.
50:6119–6129. 1990.PubMed/NCBI
|
|
11
|
Povey AC, Badawi AF, Cooper DP, et al: DNA
alkylation and repair in the large bowel: animal and human studies.
J Nutr. 132:3518S–3521S. 2002.PubMed/NCBI
|
|
12
|
Anacleto C, Leopoldino AM, Rossi B, et al:
Colorectal cancer ‘methylator phenotype’: fact or artifact?
Neoplasia. 7:331–335. 2005.
|
|
13
|
Anacleto C, Rossi B, Lopes A, et al:
Development and application of a multiplex PCR procedure for the
detection of DNA methylation in colorectal cancer. Oncol Rep.
13:325–328. 2005.PubMed/NCBI
|
|
14
|
Fox EJ, Leahy DT, Geraghty R, et al:
Mutually exclusive promoter hypermethylation patterns of hMLH1 and
O6-methylguanine DNA methyltransferase in colorectal cancer. J Mol
Diagn. 8:68–75. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim YH, Petko Z, Dzieciatkowski S, et al:
CpG island methylation of genes accumulates during the adenoma
progression step of the multistep pathogenesis of colorectal
cancer. Genes Chromosomes Cancer. 45:781–789. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen L, Kondo Y, Rosner GL, et al: MGMT
promoter methylation and field defect in sporadic colorectal
cancer. J Natl Cancer Inst. 97:1330–1338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagasaka T, Goel A, Notohara K, et al:
Methylation pattern of the O6-methylguanine-DNA methyltransferase
gene in colon during progressive colorectal tumorigenesis. Int J
Cancer. 122:2429–2436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee KH, Lee JS, Nam JH, et al: Promoter
methylation status of hMLH1, hMSH2, and MGMT genes in colorectal
cancer associated with adenoma-carcinoma sequence. Langenbecks Arch
Surg. 396:1017–1026. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Menigatti M, Truninger K, Gebbers JO,
Marbet U, Marra G and Schär P: Normal colorectal mucosa exhibits
sex- and segment-specific susceptibility to DNA methylation at the
hMLH1 and MGMT promoters. Oncogene. 28:899–909. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rakyan VK, Down TA, Thorne NP, et al: An
integrated resource for genome-wide identification and analysis of
human tissue-specific differentially methylated regions (tDMRs).
Genome Res. 18:1518–1529. 2008.
|
|
21
|
Lofton-Day C, Model F, Devos T, et al: DNA
methylation biomarkers for blood-based colorectal cancer screening.
Clin Chem. 54:414–423. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grützmann R, Molnar B, Pilarsky C, et al:
Sensitive detection of colorectal cancer in peripheral blood by
septin 9 DNA methylation assay. PLoS One. 3:e37592008.PubMed/NCBI
|
|
23
|
Gazzoli I, Loda M, Garber J, Syngal S and
Kolodner RD: A hereditary nonpolyposis colorectal carcinoma case
associated with hypermethylation of the MLH1 gene in normal tissue
and loss of heterozygosity of the unmethylated allele in the
resulting microsatellite instability-high tumor. Cancer Res.
62:3925–3928. 2002.
|
|
24
|
Miyakura Y, Sugano K, Akasu T, et al:
Extensive but hemiallelic methylation of the hMLH1 promoter region
in early-onset sporadic colon cancers with microsatellite
instability. Clin Gastroenterol Hepatol. 2:147–156. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sheng JQ, Zhang H, Ji M, et al: Genetic
diagnosis strategy of hereditary non-polyposis colorectal cancer.
World J Gastroenterol. 15:983–989. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou HH, Yan SY, Zhou XY, et al: MLH1
promoter germline-methylation in selected probands of Chinese
hereditary non-polyposis colorectal cancer families. World J
Gastroenterol. 14:7329–7334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Psofaki V, Kalogera C, Tzambouras N, et
al: Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in
colorectal adenomas. World J Gastroenterol. 16:3553–3560. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Candiloro IL and Dobrovic A: Detection of
MGMT promoter methylation in normal individuals is strongly
associated with the T allele of the rs16906252 MGMT promoter single
nucleotide polymorphism. Cancer Prev Res (Phila). 2:862–867. 2009.
View Article : Google Scholar
|
|
29
|
Vineis P, Chuang SC, Vaissière T, et al:
DNA methylation changes associated with cancer risk factors and
blood levels of vitamin metabolites in a prospective study.
Epigenetics. 6:195–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wojdacz TK and Dobrovic A:
Methylation-sensitive high resolution melting (MS-HRM): a new
approach for sensitive and high-throughput assessment of
methylation. Nucleic Acids Res. 35:e412007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Balic M, Pichler M, Strutz J, et al: High
quality assessment of DNA methylation in archival tissues from
colorectal cancer patients using quantitative high-resolution
melting analysis. J Mol Diagn. 11:102–108. 2009. View Article : Google Scholar
|
|
32
|
Landis JR and Koch GG: The measurement of
observer agreement for categorical data. Biometrics. 33:159–174.
1977. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Esteller M, Sparks A, Toyota M, et al:
Analysis of adenomatous polyposis coli promoter hypermethylation in
human cancer. Cancer Res. 60:4366–4371. 2000.PubMed/NCBI
|
|
34
|
Chan AO, Broaddus RR, Houlihan PS, Issa
JP, Hamilton SR and Rashid A: CpG island methylation in aberrant
crypt foci of the colorectum. Am J Pathol. 160:1823–1830. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ahlquist T, Lind GE, Costa VL, et al: Gene
methylation profiles of normal mucosa, and benign and malignant
colorectal tumors identify early onset markers. Mol Cancer.
7:942008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nakagawa H, Nuovo GJ, Zervos EE, et al:
Age-related hypermethylation of the 5′ region of MLH1 in normal
colonic mucosa is associated with microsatellite-unstable
colorectal cancer development. Cancer Res. 61:6991–6995. 2001.
|
|
37
|
Meng W, Huebner A, Shabsigh A, Chakravarti
A and Lautenschlaeger T: Combined RASSF1A and RASSF2A promoter
methylation analysis as diagnostic biomarker for bladder cancer.
Mol Biol Int. 2012:7018142012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Morandi L, Franceschi E, de Biase D, et
al: Promoter methylation analysis of O6-methylguanine-DNA
methyltransferase in glioblastoma: detection by locked nucleic acid
based quantitative PCR using an imprinted gene (SNURF) as a
reference. BMC Cancer. 10:482010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Avraham A, Uhlmann R, Shperber A, et al:
Serum DNA methylation for monitoring response to neoadjuvant
chemotherapy in breast cancer patients. Int J Cancer.
131:E1166–E1172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kristensen LS, Mikeska T, Krypuy M and
Dobrovic A: Sensitive Melting Analysis after Real Time- Methylation
Specific PCR (SMART-MSP): high-throughput and probe-free
quantitative DNA methylation detection. Nucleic Acids Res.
36:e422008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lim U, Flood A, Choi SW, et al: Genomic
methylation of leukocyte DNA in relation to colorectal adenoma
among asymptomatic women. Gastroenterology. 134:47–55. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pufulete M, Al-Ghnaniem R, Leather AJ, et
al: Folate status, genomic DNA hypomethylation, and risk of
colorectal adenoma and cancer: a case control study.
Gastroenterology. 124:1240–1248. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lind GE, Thorstensen L, Løvig T, et al: A
CpG island hypermethylation profile of primary colorectal
carcinomas and colon cancer cell lines. Mol Cancer. 3:282004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee S, Hwang KS, Lee HJ, Kim JS and Kang
GH: Aberrant CpG island hypermethylation of multiple genes in
colorectal neoplasia. Lab Invest. 84:884–893. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ally MS, Al-Ghnaniem R and Pufulete M: The
relationship between gene-specific DNA methylation in leukocytes
and normal colorectal mucosa in subjects with and without
colorectal tumors. Cancer Epidemiol Biomarkers Prev. 18:922–928.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Moore LE, Pfeiffer RM, Poscablo C, et al:
Genomic DNA hypomethylation as a biomarker for bladder cancer
susceptibility in the Spanish Bladder Cancer Study: a case-control
study. Lancet Oncol. 9:359–366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang L, Aakre JA, Jiang R, et al:
Methylation markers for small cell lung cancer in peripheral blood
leukocyte DNA. J Thorac Oncol. 5:778–785. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hsiung DT, Marsit CJ, Houseman EA, et al:
Global DNA methylation level in whole blood as a biomarker in head
and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev.
16:108–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Widschwendter M, Apostolidou S, Raum E, et
al: Epigenotyping in peripheral blood cell DNA and breast cancer
risk: a proof of principle study. PLoS One. 3:e26562008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
McKay JA, Xie L, Harris S, Wong YK, Ford D
and Mathers JC: Blood as a surrogate marker for tissue-specific DNA
methylation and changes due to folate depletion in post-partum
female mice. Mol Nutr Food Res. 55:1026–1035. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Christensen BC, Houseman EA, Marsit CJ, et
al: Aging and environmental exposures alter tissue-specific DNA
methylation dependent upon CpG island context. PLoS Genet.
5:e10006022009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Walsh CP and Bestor TH: Cytosine
methylation and mammalian development. Genes Dev. 13:26–34. 1999.
View Article : Google Scholar : PubMed/NCBI
|
